Similarly, abundant MMP-11 (Chenard et al, 1996) and MMP-2 (Talvensaari-Mattila et al, 2003) immunoreactivity in tissue from patients with breast cancer corresponded to a shorter disease-free survival and poorer overall survival. Here, MMP2 is linked to breast carcinoma.